Alvotech (ALVOW) EBITDA (2021 - 2025)
Alvotech (ALVOW) reported EBITDA of $22.0 million for Q4 2025, up 109.47% on a YoY basis from $10.5 million in Q4 2024, and up 107.14% quarter-over-quarter from -$308.7 million in Q3 2025.
Alvotech (ALVOW) EBITDA (2021 - 2025) Analysis & Trends
Alvotech has reported EBITDA for 5 years, with the latest figure at $22.0 million in Q4 2025.
- For the quarter ending Q4 2025, EBITDA rose 109.47% year-over-year to $22.0 million; the trailing twelve-month figure through Dec 2025 stood at -$141.5 million (up 64.27% YoY), and the FY2025 full-year result was $78.2 million, up 12.3% from the prior year.
- EBITDA for Q4 2025 stood at $22.0 million, up from -$308.7 million in the prior quarter.
- The five-year high for EBITDA was $364.7 million in Q2 2025, with the low at -$551.8 million in Q4 2023.
- Historically, EBITDA has averaged -$86.3 million across 5 years, with a median of -$79.5 million in 2021.
- The largest YoY upside for EBITDA was 137.43% in 2025 against a maximum downside of 99900.0% in 2025.
- Alvotech's EBITDA stood at $253.9 million in 2021, then plunged by 304.7% to -$519.7 million in 2022, then dropped by 6.18% to -$551.8 million in 2023, then jumped by 57.86% to -$232.6 million in 2024, then jumped by 109.47% to $22.0 million in 2025.
- The last three EBITDA figures came in at $22.0 million (Q4 2025), -$308.7 million (Q3 2025), and $364.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -98.81 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 81.33 Mn |
| 10 | Alvotech | - | - | -22.39 Mn | 22.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.03 Mn |
| Sep 30, 2025 | -308.70 Mn |
| Jun 30, 2025 | 364.70 Mn |
| Mar 31, 2025 | -219.55 Mn |
| Dec 31, 2024 | -232.55 Mn |
| Sep 30, 2024 | -316.93 Mn |
| Jun 30, 2024 | 153.60 Mn |
| Mar 31, 2024 | -219,549.00 |
| Dec 31, 2023 | -551.82 Mn |
| Aug 31, 2023 | -189.10 Mn |
| Jun 30, 2023 | 88.65 Mn |
| Mar 31, 2023 | -275,532.00 |
| Dec 31, 2022 | -519.69 Mn |
| Aug 31, 2022 | -203.58 Mn |
| Jun 30, 2022 | 265.78 Mn |
| Mar 31, 2022 | -77.06 Mn |
| Dec 31, 2021 | 253.88 Mn |
| Sep 30, 2021 | -81.99 Mn |